Hosted on MSN
Identifying High-Risk Multiple Myeloma
While the introduction of novel therapies has led to substantial improvements in the outcomes of patients with newly diagnosed multiple myeloma, there remains a high-risk population of patients who ...
PROVO, Utah, Feb. 10, 2026 /PRNewswire/ -- Canary Speech, a leader in vocal biomarker technology, today announced a partnership with Intermountain Ventures, the venture capital and innovation arm of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results